• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ishita Drugs & Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3314.0
  • ISIN : INE806D01016
73.14 -2 (-2.48%)
  • As on 03 Sep 2025 (EOD)
  • Today’s Low

    73.00
  • Today’s High

    74.50
  • Open

    73.06
  • Perv Close

    75.00
  • 52W Low

    62.35
  • 52W High

    99.64

Key Indicators

  • P/E(TTM)

    21.93

  • Mar.Cap (₹Cr.)

    22.43

  • Div & Yield %

    0.00

  • Book Value(₹)

    36.09

  • Debt-Equity Ratio

    -2.48

  • AGM Date

    03-Sep-2025

  • EPS

    3.42

  • P/E Ratio

    21.93

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    22.43

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.99

  • BV (₹)

    36.10

  • Sales( ₹ in Cr.)

    15.00

  • NP (in Cr.)

    0.87

  • NP Var(%)

    16.0

  • Div%

    0.0

  • CPS (₹)

    3.30

  • EPS (₹)

    2.90

  • Traded Value (₹ in Lakhs)

    22.43

  • 52 Week High

    99.64

  • 52 Week Low

    62.35

  • Price BSE

    75.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    22.43

  • P/C Ratio

    22.90

  • P/E Ratio

    25.80

  • Price Vs.BV

    2.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 15.19 12.07 14.09 13.95 14.83 9.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 15.19 12.07 14.09 13.95 14.83 9.09
Other Income 0.28 0.20 0.11 0.31 0.16 0.16
Stock Adjustments 0.15 0.13 0.03 -0.09 0.00 -0.13
Total Income 15.62 12.40 14.23 14.17 14.99 9.12
EXPENDITURE :            
Raw Materials 11.44 8.69 10.20 10.20 11.45 6.27
Power and Fuel Cost 0.16 0.17 0.23 0.24 0.24 0.24
Employee Cost 0.83 0.77 0.76 0.76 0.76 0.67
Other Manufacturing Expenses 0.33 0.33 0.40 0.43 0.49 0.39
Selling and Administration Expenses 1.67 1.48 1.44 1.30 1.13 0.87
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expenses 0.83 0.77 0.76 0.76 0.76 0.67
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 14.43 11.45 13.03 12.94 14.07 8.44
Operating Profit 1.19 0.96 1.19 1.23 0.92 0.68
Interest 0.09 0.05 0.02 0.03 0.03 0.06
Gross Profit 1.10 0.91 1.17 1.20 0.89 0.62
Depreciation 0.11 0.13 0.13 0.15 0.18 0.16
Profit Before Tax 0.99 0.78 1.04 1.05 0.71 0.46
Current Tax 0.24 0.21 0.25 0.23 0.18 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -0.01 -0.01 -0.01 -0.01 0.00
Reported Net Profit 0.75 0.58 0.80 0.83 0.55 0.35
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.75 0.58 0.80 0.83 0.55 0.35
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 6.02 5.44 4.63 3.80 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.55 0.35
P & L Balance carried down 6.76 6.02 5.44 4.63 0.00 0.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.50 1.93 2.69 2.77 1.83 1.18
Earnings Per Share(Adj)-Unit Curr 2.50 1.93 2.69 2.77 1.83 1.18
Book Value 33.18 30.68 28.75 26.05 23.28 21.45
Book Value(Adj)-Unit Curr 33.18 30.68 28.75 26.05 23.28 21.45

Shareholding Pattern

  • Promoter Group

    49.92%

  • Public Share Holding

    50.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 427,300 14.29 427,300 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,065,377 35.63 1,065,377 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,492,677 49.92 1,492,677 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 21,715 0.73 18,615 18
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,429 0.15 4,429 14
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 59,291 1.98 59,291 39
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 323,608 10.82 323,608 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,074,576 35.94 653,136 5,245
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 13,904 0.47 13,904 3
Sub Total 1,497,623 50.08 1,073,083 5,329
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,990,300 100.00 2,565,760 5,341

Company Background

Ishita Drugs & Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Ishita Drugs & Industries Ltd
  • BSE Code : 3314.0
  • ISIN : INE806D01016
  • Incorporation Year

    1992

  • Registered Office

    Survey No 179/1 Taluka Sanand
    Village Vasna-Iyava, Ahmedabad,
    Gujarat-382170

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Jagdish Agrawal

  • Company Secretary

    Srushti Pandya

  • Auditor

    jaymin Shah & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Big Share Services Pvt Ltd
    E-2/3 Saki Vihar Rd ,
    Ansa Indl Estate ,Saki Naka Andheri-E
    Mumbai - Mumbai - 400 072

Ishita Drugs & Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ishita Drugs 75.00 15.47 15.19 21.93 10.77
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10